Showing results (121-130 of 160) with videos related to
Sort By:
Pageof 16
Elife|August 23, 2017
Type III CRISPR-Cas systems can provide redundancy to counteract viral escape from type I systemsSukrit Silas, Patricia Lucas-Elio, Simon A Jackson, et al.Nature Structural & Molecular Biology|January 18, 2011
A processed noncoding RNA regulates an altruistic bacterial antiviral systemTim R Blower, Xue Y Pei, Francesca L Short, et al.Nature Communications|November 7, 2020
Discovery of multiple anti-CRISPRs highlights anti-defense gene clustering in mobile genetic elementsRafael Pinilla-Redondo, Saadlee Shehreen, Nicole D Marino, et al.Nature Microbiology|August 31, 2016
Inactivation of CRISPR-Cas systems by anti-CRISPR proteins in diverse bacterial speciesApril Pawluk, Raymond H J Staals, Corinda Taylor, et al.Nucleic Acids Research|March 22, 2012
Identification and classification of bacterial Type III toxin-antitoxin systems encoded in chromosomal and plasmid genomesTim R Blower, Francesca L Short, Feng Rao, et al.Nature|October 18, 2023
Bacteriophages suppress CRISPR-Cas immunity using RNA-based anti-CRISPRsSarah Camara-Wilpert, David Mayo-Muñoz, Jakob Russel, et al.Nucleic Acids Research|October 4, 2021
Identification and classification of antiviral defence systems in bacteria and archaea with PADLOC reveals new system typesLeighton J Payne, Thomas C Todeschini, Yi Wu, et al.Molecular Cell|November 22, 2016
Quorum Sensing Controls Adaptive Immunity through the Regulation of Multiple CRISPR-Cas SystemsAdrian G Patterson, Simon A Jackson, Corinda Taylor, et al.RNA Biology|March 29, 2013
CRISPR-Cas systems preferentially target the leading regions of MOBF conjugative plasmidsEdze R Westra, Raymond H J Staals, Gerrit Gort, et al.The Biochemical Journal|March 2, 2016
Structural plasticity and in vivo activity of Cas1 from the type I-F CRISPR-Cas systemMax E Wilkinson, Yoshio Nakatani, Raymond H J Staals, et al.Pageof 16